Sandford E, Burmeister M. Genes and genetic testing in hereditary ataxias. Genes (Basel). 2014;5(3):586–603.

Article  PubMed  Google Scholar 

Yahia A, Stevanin G. The History of gene hunting in hereditary spinocerebellar degeneration: lessons from the past and future perspectives. Front Genet. 2021;12: 638730.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Synofzik M, Puccio H, Mochel F, Schols L. Autosomal recessive cerebellar ataxias: paving the way toward targeted molecular therapies. Neuron. 2019;101(4):560–83.

Article  CAS  PubMed  Google Scholar 

Synofzik M, Nemeth AH. Recessive ataxias. Handb Clin Neurol. 2018;155:73–89.

Article  PubMed  Google Scholar 

Gama MTD, Braga-Neto P, Rangel DM, Godeiro C Jr, Alencar R, Embirucu EK, et al. Autosomal recessive cerebellar ataxias in south america: a multicenter study of 1338 patients. Mov Disord. 2022;37(8):1773–4.

Article  PubMed  Google Scholar 

Ngo KJ, Rexach JE, Lee H, Petty LE, Perlman S, Valera JM, et al. A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders. Hum Mutat. 2020;41(2):487–501.

Article  CAS  PubMed  Google Scholar 

Vazquez-Mojena Y, Leon-Arcia K, Gonzalez-Zaldivar Y, Rodriguez-Labrada R, Velazquez-Perez L. Gene therapy for polyglutamine spinocerebellar ataxias: advances, challenges, and perspectives. Mov Disord. 2021;36(12):2731–44.

Article  CAS  PubMed  Google Scholar 

Klockgether T, Ashizawa T, Brais B, Chuang R, Durr A, Fogel B, et al. Paving the way toward meaningful trials in ataxias: an ataxia global initiative perspective. Mov Disord. 2022;37(6):1125–30.

Article  PubMed  Google Scholar 

Synofzik M, Gonzalez MA, Lourenco CM, Coutelier M, Haack TB, Rebelo A, et al. PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. Brain. 2014;137(Pt 1):69–77.

Article  PubMed  Google Scholar 

Traschutz A, Reich S, Adarmes AD, Anheim M, Ashrafi MR, Baets J, et al. The ARCA registry: a collaborative global platform for advancing trial readiness in autosomal recessive cerebellar ataxias. Front Neurol. 2021;12: 677551.

Article  PubMed  PubMed Central  Google Scholar 

Gonzalez M, Falk MJ, Gai X, Postrel R, Schule R, Zuchner S. Innovative genomic collaboration using the GENESIS (GEM.app) platform. Hum Mutat. 2015;36(10):950–6.

Article  PubMed  PubMed Central  Google Scholar 

Laurie S, Piscia D, Matalonga L, Corvo A, Fernandez-Callejo M, Garcia-Linares C, et al. The RD-Connect Genome-Phenome Analysis Platform: accelerating diagnosis, research, and gene discovery for rare diseases. Hum Mutat. 2022;43(6):717–33.

CAS  PubMed  PubMed Central  Google Scholar 

Traschutz A, Cortese A, Reich S, Dominik N, Faber J, Jacobi H, et al. Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1 disease. Neurology. 2021;96(9):e1369–82.

Article  PubMed  PubMed Central  Google Scholar 

Pellerin D, Danzi M, Wilke C, Renaud M, Fazal S, Scriba C, et al. Deep intronic FGF14 GAA repeat expansion in late-onset cerebellar ataxia. N Engl J Med. 2022;in press.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.

Article  PubMed  PubMed Central  Google Scholar 

Preston CG, Wright MW, Madhavrao R, Harrison SM, Goldstein JL, Luo X, et al. ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines. Genome Med. 2022;14(1):6.

Article  PubMed  PubMed Central  Google Scholar 

Fazal S, Danzi MC, van Kuilenburg ABP, Reich S, Traschutz A, Bender B, et al. Repeat expansions nested within tandem CNVs: a unique structural change in GLS exemplifies the diagnostic challenges of non-coding pathogenic variation. Hum Mol Genet. 2023;32(1):46–54. https://doi.org/10.1093/hmg/ddac173.

Cipriani V, Pontikos N, Arno G, Sergouniotis PI, Lenassi E, Thawong P, et al. An improved phenotype-driven tool for rare mendelian variant prioritization: benchmarking exomiser on real patient whole-exome data. Genes (Basel). 2020;11(4):460. https://doi.org/10.3390/genes11040460.

Danzi M, Dohrn M, Fazal S, Beijer D, Rebelo A, Cintra V, et al. Deep structured learning realizes variant prioritization for Mendelian diseases. Preprint from Research Square. 2022. https://doi.org/10.21203/rs.3.rs-1602211/v1.

Rath A, Olry A, Dhombres F, Brandt MM, Urbero B, Ayme S. Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users. Hum Mutat. 2012;33(5):803–8.

Article  PubMed  Google Scholar 

Robinson PN, Kohler S, Bauer S, Seelow D, Horn D, Mundlos S. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet. 2008;83(5):610–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Philippakis AA, Azzariti DR, Beltran S, Brookes AJ, Brownstein CA, Brudno M, et al. The Matchmaker Exchange: a platform for rare disease gene discovery. Hum Mutat. 2015;36(10):915–21.

Article  PubMed  PubMed Central  Google Scholar 

Bis-Brewer DM, Gan-Or Z, Sleiman P, Inherited Neuropathy C, Hakonarson H, Fazal S, et al. Assessing non-Mendelian inheritance in inherited axonopathies. Genet Med. 2020;22(12):2114–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matar A, Hansson M, Slokenberga S, Panagiotopoulos A, Chassang G, Tzortzatou O, et al. A proposal for an international Code of Conduct for data sharing in genomics. Dev World Bioeth. 2022. https://doi.org/10.1111/dewb.12381.

Synofzik M, van Roon-Mom WMC, Marckmann G, van Duyvenvoorde HA, Graessner H, Schule R, et al. Preparing n-of-1 antisense oligonucleotide treatments for rare neurological diseases in europe: genetic, regulatory, and ethical perspectives. Nucleic Acid Ther. 2022;32(2):83–94. https://doi.org/10.1089/nat.2021.0039.

Atalaia A, Thompson R, Corvo A, Carmody L, Piscia D, Matalonga L, et al. A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome. Orphanet J Rare Dis. 2020;15(1):206.

Article  PubMed  PubMed Central  Google Scholar 

Thompson R, Bonne G, Missier P, Lochmuller H. Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome. Emerg Top Life Sci. 2019;3(1):19–37.

Article  CAS  PubMed  PubMed Central  Google Scholar